The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery

SIMPLE SUMMARY: The biopharmaceutical industry increasingly focuses on the development of new anticancer drugs for effective cancer therapy. Despite these efforts, the success rate is low, and thereby, greater efficacy and better safety properties are required. The high failure rate in drug discover...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, JuneSung, Choi, Yun Sik, Cho, Gunsik, Jang, Se Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105149/
https://www.ncbi.nlm.nih.gov/pubmed/35565273
http://dx.doi.org/10.3390/cancers14092144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105149/
https://www.ncbi.nlm.nih.gov/pubmed/35565273
http://dx.doi.org/10.3390/cancers14092144

Ejemplares similares